Announcements Trials

Browse Landscape

Phase

Phase NA 120 Phase 3 16 Phase 2 9 Phase 4 8 Phase 2/3 3 Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 699 Breast Neoplasms 629 Neoplasms 582 Leukemia, Myeloid, Acute 481 Colorectal Neoplasms 455 Multiple Myeloma 444 Melanoma 424 Prostatic Neoplasms 383 Neoplasm Metastasis 370 Pancreatic Neoplasms 361 Recurrence 347 Lymphoma 340 Ovarian Neoplasms 322 Lung Neoplasms 297 Lymphoma, Non-Hodgkin 295 Leukemia 287 Glioblastoma 275 Precursor Cell Lymphoblastic Leukemia-Lymphoma 249 Stomach Neoplasms 246 Leukemia, Lymphocytic, Chronic, B-Cell 235 Carcinoma, Hepatocellular 231 Squamous Cell Carcinoma of Head and Neck 219 Lymphoma, Large B-Cell, Diffuse 217 Myelodysplastic Syndromes 212 Carcinoma, Renal Cell 210 Lymphoma, Follicular 183 Head and Neck Neoplasms 172 Brain Neoplasms 169 Triple Negative Breast Neoplasms 167 Lymphoma, Mantle-Cell 167

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Postoperative Complications × Clear all

NCT02943694 2016-10-25

FSI-TaTME

Ruijin Hospital

Phase 1/2 Unknown

Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡